NCT00189540View on ClinicalTrials.gov

Study of Hepatocyte Growth Factor (HGF) Via Plasmid Vector to Improve Perfusion in Critical Limb Ischemia Patients With Peripheral Ischemic Ulcers

PHASE2CompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

August 31, 2005

Primary Completion Date

July 31, 2008

Study Completion Date

August 31, 2008

Conditions
Arterial Occlusive DiseasePeripheral Vascular DiseaseIschemiaUlcers
Interventions
GENETIC

HGF plasmid

Intramuscular injections into the index leg on days 0, 14, and 28

GENETIC

Placebo

Intramuscular injections into the index leg on days 0, 14, and 28

Trial Locations (4)

32501

Baptist Clinical Research, Pensacola

46290

The Care Group, LLC, Indianapolis

02118

Boston Medical Center, Boston

03756

Dartmouth - Hitchcock Medical Center, Lebanon

All Listed Sponsors
lead

AnGes USA, Inc.

INDUSTRY

NCT00189540 - Study of Hepatocyte Growth Factor (HGF) Via Plasmid Vector to Improve Perfusion in Critical Limb Ischemia Patients With Peripheral Ischemic Ulcers | Biotech Hunter | Biotech Hunter